Head-to-head comparisons of medication uses, side effects, warnings, and more.
Ibrance (palbociclib)
Verzenio (abemaciclib)
Ibrance (palbociclib)
Verzenio (abemaciclib)
Summary of Ibrance vs. Verzenio
Summary for Kinase inhibitor
Prescription only
Ibrance (palbociclib) is an oral medication used to treat certain types of advanced or metastatic breast cancer (cancer that has spread to other parts of the body). It works by stopping the uncontrolled growth of cancer cells. Ibrance (palbociclib) is taken once a day for 21 days in a 28 day cycle. But it should be used in combination with other medications that block or lower the amount of estrogen in your body.
Summary for Cyclin-dependent kinase (CDK) inhibitor
Prescription only
Verzenio (abemaciclib) is a cyclin-dependent kinase (CDK) inhibitor. It’s a targeted therapy used to treat HR+/HER2- breast cancer, including early and advanced or metastatic breast cancer. Verzenio (abemaciclib) is sometimes taken alone and sometimes along with hormone therapy, depending on the stage of cancer. It comes as a pill that’s taken by mouth twice a day. Some of the more common side effects of Verzenio (abemaciclib) include nausea, diarrhea, and fatigue. Verzenio (abemaciclib) is only available as a brand-name medication.